- Investing Ideas
- /
- Swedish Healthcare Undervalued Stocks Based On Cash Flows
Swedish Healthcare Undervalued Stocks Based On Cash Flows
Results
7
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
7 companies
Surgical Science Sweden
Market Cap: SEK 7.6b
Develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally.
SUS
SEK 148.40
7D
-0.7%
1Y
11.2%
Stille
Market Cap: SEK 2.0b
Develops, manufactures, and distributes medtech products in Sweden and internationally.
STIL
SEK 228.00
7D
0%
1Y
-6.6%
CellaVision
Market Cap: SEK 4.1b
Develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally.
CEVI
SEK 172.60
7D
-4.4%
1Y
-28.7%
Carasent
Market Cap: SEK 2.2b
Provides cloud based electronic health record (EHR) systems solutions and platform services for healthcare sector in Nordics and Germany.
CARA
SEK 30.20
7D
2.4%
1Y
n/a
SyntheticMR
Market Cap: SEK 1.2b
Engages in the development and marketing of imaging and software solutions for magnetic resonance imaging (MRI) in Sweden and internationally.
SYNT
SEK 27.70
7D
0%
1Y
-13.4%
Careium
Market Cap: SEK 666.5m
Provides technology-enabled care services in Sweden, Norway, the United Kingdom, the Netherlands, Germany, France, and Spain.
CARE
SEK 27.40
7D
-6.2%
1Y
-24.5%
Vimian Group
Market Cap: SEK 19.6b
Engages in the animal health business worldwide.
VIMIAN
SEK 35.66
7D
-15.7%
1Y
4.6%